department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Protara Therapeutics, Inc. ($TARA) · pharmadog

PUBLIC COMPANY

$TARAProtara Therapeutics, Inc.

New York, NY, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

2

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 21Phase 3

choline chloride

Unspecified Rare Disease

Upcoming

no upcoming catalysts on record

Recent

🕒

(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Protara Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$TARA

SEC CIK

0001359931

country

US

source

sec_tickers

top tags

mentioned in

0news items

entity-linker matched

$TARA

Data sources

SEC EDGAR · openFDA

last refreshed 33m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase2Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancerrecruitingn=131
phase3Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Supportrecruitingn=129
phase3Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancernot yet recruitingn=284
phase2Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Agerecruitingn=38
phase1Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)completedn=10
phase1Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)completedn=12
—Prevalence of Liver Disease in Patients Dependent on Parenteral Nutritioncompletedn=80

Insider activity

source: SEC Form 4

90d open-market buys

$0

0 transactions

90d open-market sells

$6K

1 transaction

net (buys − sells)

−$6K

non-derivative only

open-market buys + sells

Apr 8, 26SELLZummo Jacqueline· Chief R&D Officer1,134 sh @ $5.40−$6K↗
Apr 1, 26SELLZummo Jacqueline· Chief R&D Officer22,598 sh @ $5.26−$119K↗